Moreover, the anti-cancer proprieties of bilirubin have been documented, with bilirubin administration i.p. in mice increasing plasma bilirubin up to 40μM and drastically reducing colon cancer growth via activation of ERK1/2 (Ollinger et al., 2007). This evidence concerns the gene MAPK3 and malignant colon neoplasm.